Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 3
2014 3
2015 3
2016 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar J, Williams H, Field TS, Manosalva A, Siddiqui M, Zafar A, Imoukhuede O, Hunter G, Demchuk AM, Mishra S, Gioia LC, Jalini S, Cayer C, Phillips S, Elamin E, Shoamanesh A, Subramaniam S, Kate M, Jacquin G, Camden MC, Benali F, Alhabli I, Bala F, Horn M, Stotts G, Hill MD, Gladstone DJ, Poppe A, Sehgal A, Zhang Q, Lethebe BC, Doram C, Ademola A, Shamy M, Kenney C, Sajobi TT, Swartz RH; AcT Trial Investigators. Menon BK, et al. Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29. Lancet. 2022. PMID: 35779553 Clinical Trial.
Emerging drugs for levodopa-induced dyskinesia.
Al Dakheel A, Beaulieu-Boire I, Fox SH. Al Dakheel A, et al. Among authors: beaulieu boire i. Expert Opin Emerg Drugs. 2014 Sep;19(3):415-29. doi: 10.1517/14728214.2014.955014. Epub 2014 Aug 22. Expert Opin Emerg Drugs. 2014. PMID: 25146568 Review.
Behavioral effects of levodopa.
Beaulieu-Boire I, Lang AE. Beaulieu-Boire I, et al. Mov Disord. 2015 Jan;30(1):90-102. doi: 10.1002/mds.26121. Epub 2014 Dec 9. Mov Disord. 2015. PMID: 25491470
Deep Brain Stimulation in Rare Inherited Dystonias.
Beaulieu-Boire I, Aquino CC, Fasano A, Poon YY, Fallis M, Lang AE, Hodaie M, Kalia SK, Lozano A, Moro E. Beaulieu-Boire I, et al. Brain Stimul. 2016 Nov-Dec;9(6):905-910. doi: 10.1016/j.brs.2016.07.009. Epub 2016 Oct 4. Brain Stimul. 2016. PMID: 27743838
Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events.
Yu AYX, Hill MD, Asdaghi N, Boulanger JM, Camden MC, Campbell BCV, Demchuk AM, Field TS, Goyal M, Krause M, Mandzia J, Menon BK, Mikulik R, Moreau F, Penn AM, Swartz RH, Coutts SB; Diagnosis of Uncertain-Origin Benign Transient Neurological Symptoms (DOUBT) Study Group. Yu AYX, et al. Neurology. 2021 Feb 2;96(5):e732-e739. doi: 10.1212/WNL.0000000000011212. Epub 2020 Nov 12. Neurology. 2021. PMID: 33184228 Free PMC article.
Baduanjin Qigong Intervention by Telerehabilitation (TeleParkinson): A Proof-of-Concept Study in Parkinson's Disease.
Carvalho LP, Décary S, Beaulieu-Boire I, Dostie R, Lalonde I, Texier É, Laprise L, Pepin E, Gilbert M, Corriveau H, Tousignant M. Carvalho LP, et al. Among authors: beaulieu boire i. Int J Environ Res Public Health. 2021 Jun 30;18(13):6990. doi: 10.3390/ijerph18136990. Int J Environ Res Public Health. 2021. PMID: 34208823 Free PMC article.
12 results